Dermira's Series B Round

Dermira raised a round of funding on June 11, 2013.

Dermira is focused on developing and commercializing new therapies in dermatology. The company's portfolio of dermatology therapeutics includes lemuteporfin, a potent and selective topical photodynami…

Articles about Dermira's Series B Round: